NeuroOne Medical Technologies Corporation
NMTC · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,605 | -$12,318 | -$11,859 | -$10,000 |
| Dep. & Amort. | $262 | $247 | $199 | $119 |
| Deferred Tax | $0 | $0 | $0 | -$11 |
| Stock-Based Comp. | $1,265 | $1,344 | $1,105 | $947 |
| Change in WC | $0 | -$955 | -$2,429 | $1,214 |
| Other Non-Cash | -$758 | $670 | $96 | $212 |
| Operating Cash Flow | -$2,837 | -$11,012 | -$12,887 | -$7,520 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$82 | -$120 | -$384 | -$275 |
| Net Acquisitions | $0 | $0 | $0 | $2,970 |
| Inv. Purchases | $0 | $0 | -$1,473 | -$3,470 |
| Inv. Sales/Matur. | $0 | $0 | $4,500 | $500 |
| Other Inv. Act. | $0 | $0 | $8 | -$2,970 |
| Investing Cash Flow | -$82 | -$120 | $2,650 | -$3,245 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,614 | $7,426 | $8,590 | $13,351 |
| Stock Repurch. | $0 | -$81 | -$119 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $141 | $1,480 | -$1,072 | -$1,327 |
| Financing Cash Flow | $141 | $7,270 | $7,399 | $12,023 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5,110 | -$3,862 | -$2,838 | $1,259 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,460 | $5,322 | $8,160 | $6,901 |
| End Cash | $6,570 | $1,460 | $5,322 | $8,160 |
| Free Cash Flow | -$2,919 | -$11,132 | -$13,271 | -$7,795 |